NCT00364377View on ClinicalTrials.gov

Incretins in Impaired Fasting Glucose

PHASE4CompletedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Pre-diabetes

Interventions

DRUG

Sitagliptin

100 mg once daily

OTHER

Placebo

once daily for duration of the study

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT00364377 - Incretins in Impaired Fasting Glucose | Biotech Hunter | Biotech Hunter